dctd.cancer.gov Open in urlscan Pro
2607:f220:41d:21c1::812b:fe68  Public Scan

Form analysis
2 forms found in the DOM

Name: SearchForm — GET /search/search.asp

<form action="/search/search.asp" method="get" enctype="application/x-www-form-urlencoded" name="SearchForm" id="SearchForm" onsubmit="return validate_search();">
  <label id="searchLabel" for="zoom_query">Search this site</label>
  <input type="text" name="zoom_query" id="zoom_query" maxlength="255" class="search" value="Search this site">
  <input class="searchButton" id="mobileSearchButton" type="image" src="/images/redesign/mb_search.png" name="Action" alt="Search">
</form>

POST https://public.govdelivery.com/accounts/USNIHNCI/subscribers/qualify

<form id="GD-snippet-form" action="https://public.govdelivery.com/accounts/USNIHNCI/subscribers/qualify" accept-charset="UTF-8" method="post" target="_blank">
  <input type="hidden" name="utf8" value="✓">
  <input type="hidden" name="authenticity_token" value="eL+dIAJsA3vynBRwExX/P98nw8dHo?hyvlwov0QEAKCZGnNuEzEWe+SPC8C6?Ta6C/rdtbYvQt2jvLz+y2hD2ouw==">
  <input type="hidden" name="topic_id" id="topic_id" value="USNIHNCI_322">
  <label id="newsletterSignUpEmailLabel" for="email">Enter email Address</label>
  <input type="text" style="margin-top: 5px;" name="email" id="email" placeholder=" Enter e-mail Address">
  <input type="submit" style="margin-top: 5px;" name="commit" value="Subscribe">
</form>

Text Content

Skip to Content
Home | Sitemap | Contact DCTD
Search this site

 * Home
 * Funding Opportunities
   * Funding Announcements
   * Grantsmanship Resources
   * Research Grants
 * Research
   * Major Initiatives
   * Research Networks
   * Scientific Advances
   * Partnerships
 * Research Resources
   * Biomarkers
   * Biometric Research
   * Cancer Diagnosis Research
   * Clinical Proteogenomics
   * Clinical Trials
   * Drug Discovery and Development
   * Imaging
   * Radiation Research
 * News & Events
   * DCTD Meetings
   * DCTD Newsletter
   * 2024 News
   * 2023 News
   * 2022 News
   * 2021 News
   * 2020 News
   * News Archive
 * Careers
 * About
   * Overview
   * Research Interests
   * DCTD Management
   * DCTD Research Grants
   * DCTD Diversity, Equity, Inclusion, and Accessibility
   * Staff Roster

 * VCTO
 * DCTD LinkedIn
 * NCI-60
 * DEIA


DCTD PROGRAMS

Biometric Research Program
Provides statistical, computational, and systems biology analyses
Cancer Diagnosis Program
Funds specimen resources and research to characterize tumors
Cancer Imaging Program
Evaluates imaging in diagnosis, disease staging, and treatment monitoring
Cancer Therapy Evaluation Program
Assesses new anticancer agents, radiation treatments, and surgical methods
Developmental Therapeutics Clinic
Conducts early-phase clinical trials of novel cancer treatment agents
Developmental Therapeutics Program
Funds drug discovery and development and provides related services
Radiation Research Program
Funds novel radiotherapy research
Translational Research Program
Integrates scientific advancements in the understanding of the biology of human
cancer
Office of Cancer Clinical Proteomics Research
Applies proteomic and proteogenomic methods to improve cancer diagnosis and
treatment
Office of Cancer Complementary and Alternative Medicine
Improves the quality of cancer research on complementary and alternative
modalities


DCTD ACTIVITIES

ETCTN
Experimental Therapeutics Clinical Trials Network
Defines approaches to cancer treatment based on molecular characterization and
biomarker assay development
NCI Formulary
NCI Formulary
Provides main-member ETCTN or NCTN investigators with rapid access to agents for
on-site, investigator-held-IND clinical or preclinical research
NCTN
National Clinical Trials Network
Maximizes knowledge of tumor biology and resources to facilitate rapid
initiation and completion of cancer clinical trials
NCTN
Navigator
NCTN Navigator
Provides a searchable database of specimens from NCTN Phase 3 clinical trials
NCTN/NCORP Data Archive
NCTN/NCORP Data Archive
Provides access to a centralized repository of patient-level data from Phase 3
clinical trials
NExT
NCI Experimental Therapeutics Program
Supports the most promising new drug discovery and development projects
PDMR
NCI Patient-Derived Models Repository
Provides early-passage, molecularly characterized, and clinically annotated
patient-derived xenograft models to the scientific community
SPOREs
Specialized Programs of Research Excellence
Promotes collaborative, interdisciplinary, translational research leading to new
approaches for prevention, early detection, diagnosis, and treatment of cancer
TCIA
The Cancer Imaging Archive
Provides de-identified radiology and histopathology image datasets to accelerate
the development of imaging based signatures of cancer biology


MESSAGE FROM THE DCTD DIRECTOR:

The Division of Cancer Treatment and Diagnosis (DCTD) focuses its activities on
developing novel diagnostics and therapies for cancer. DCTD staff members, along
with colleagues throughout the National Cancer Institute (NCI), academia, and
industry, are working to generate a seamless pipeline of biomarkers and
therapeutics that runs the gamut from initial efforts in drug discovery through
late-stage clinical trials. More…


MAJOR INITIATIVES


NEWS & EVENTS

REGISTER TO RECEIVE DCTD NEWS AND UPDATES

Enter email Address
Follow DCTD on LinkedIn

DCTD Meetings
DCTD Programs and Initiatives Book (2018-2019)
Contribute Data to the NCI Integrated Canine Data Commons
The Cancer Imaging Program Convenes the 2024 Co-Clinical Imaging Research
Resource Program Annual Hybrid Meeting and Joint Workshop on the Co-Clinical
Imaging Roadmap
Summary and Recordings from the NCI Synthetic Biology for Molecular Imaging in
Cancer Workshop
Summary and Recordings from the NCI Workshop on Digital Pathology Imaging (DPI)
in Cancer Clinical Trials and Research
NCI Blog Posts Featuring DCTD Staff
Study identifies hundreds of potential targets for cancer drugs
More immunotherapy options approved for treating endometrial cancer
ctDNA may guide who needs chemo after colorectal cancer surgery


FEATURED TRIALS

Exceptional Responders StudyClick here to view all DCTD Featured Trials
Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in
Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative
Breast CancerClick here to view all DCTD Featured Trials
 * DCTD Home
 * Contact DCTD
 * Site Map
 * Accessibility
 * Disclaimer Policy
 * FOIA
 * HHS Vulnerability Disclosure

 * U.S. Department of Health and Human Services
 * National Institutes of Health
 * National Cancer Institute
 * USA.gov

NIH… Turning Discovery Into Health®